SVB Leerink Reiterates Outperform on Deciphera Pharmaceuticals, Maintains $30 Price Target

SVB Leerink analyst Andrew Berens reiterates Deciphera Pharmaceuticals (NASDAQ:DCPH) with a Outperform and maintains $30 price target.

byBenzinga Newsdesk

February 8, 2023

1 minute read

SVB Leerink analyst Andrew Berens reiterates Deciphera Pharmaceuticals (NASDAQ:DCPH) with a Outperform and maintains $30 price target.

Elon Musk Derides President Biden Over Failure To Acknowledge SpaceX’s 1st All-Civilian Mission

By Rachit Vats

Today, 8:26 AM

SpaceX CEO Elon Musk on Sunday ridiculed U.S. President Joe Biden for failing to acknowledge the efforts of his aerospace company in successfully executing and returning an all-civilian space mission back to earth.

AMZN

Needham Initiates Coverage On ThredUp with Buy Rating, Announces Price Target of $35

By Benzinga Newsdesk

Today, 8:26 AM

Needham analyst Anna Andreeva initiates coverage on ThredUp (NASDAQ:TDUP) with a Buy rating and announces Price Target of $35.

TDUP

Bitcoin Edges Up, Ethereum, Dogecoin Down: Fed Meet Cheers Stocks But Crypto Stuck In Rut

By Shivdeep Dhaliwal

Today, 8:26 AM

Bitcoin and Ethereum were mixed at press time on Wednesday evening, breaking away from other risk assets after the U.S. Federal Reserve’s policy meeting minutes came in line with expectations. The global cryptocurrency market cap fell 0.7% to $1.3 trillion.

$DOGE

JP Morgan Initiates Coverage On EVgo with Overweight Rating, Announces Price Target of $20

By Benzinga Newsdesk

Today, 8:26 AM

JP Morgan analyst Bill Peterson initiates coverage on EVgo (NASDAQ:EVGO) with a Overweight rating and announces Price Target of $20.

EVGO

SVB Leerink Reiterates Outperform on Deciphera Pharmaceuticals, Maintains $30 Price Target

Related Posts

Elon Musk Derides President Biden Over Failure To Acknowledge SpaceX’s 1st All-Civilian Mission

Needham Initiates Coverage On ThredUp with Buy Rating, Announces Price Target of $35

Bitcoin Edges Up, Ethereum, Dogecoin Down: Fed Meet Cheers Stocks But Crypto Stuck In Rut

JP Morgan Initiates Coverage On EVgo with Overweight Rating, Announces Price Target of $20